Last updated on November 2017

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Parallel-Group Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older with Insomnia Disorder


Brief description of study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Parallel-Group Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older with Insomnia Disorder

Detailed Study Description

Eisai is studying a drug called lemborexant or E2006, being developed to potentially treat people with insomnia disorder. The main goal of this study is to compare the effectiveness of two strengths of lemborexant with another drug called zolpidem tartrate extended release tablets (also known as Ambien® Controlled Release tablets) and placebo.

Clinical Study Identifier: TX8289

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Clinilabs, Inc

Clinilabs, Inc
New York, NY USA
  Connect »

Clinilabs, Inc

Clinilabs, Inc
Eatontown, NJ USA
  Connect »